Geratherm Medical AG (GME.DE)
- Previous Close
4.0800 - Open
4.0800 - Bid 3.9800 x 14100
- Ask 4.1600 x 69700
- Day's Range
4.0800 - 4.0800 - 52 Week Range
3.7000 - 7.6000 - Volume
900 - Avg. Volume
1,413 - Market Cap (intraday)
22.144M - Beta (5Y Monthly) -0.05
- PE Ratio (TTM)
22.67 - EPS (TTM)
0.1800 - Earnings Date Jun 20, 2024
- Forward Dividend & Yield 0.15 (3.68%)
- Ex-Dividend Date Aug 29, 2023
- 1y Target Est
9.20
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment offers MRI-compatible incubators for premature babies under the LMT brand. The Cardio/Stroke segment offers stroke risk analysis products for the detection of atrial fibrillation. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. The company was founded in 1990 and is headquartered in Geschwenda, Germany.
www.geratherm.comRelated News
Performance Overview: GME.DE
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GME.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GME.DE
Valuation Measures
Market Cap
22.14M
Enterprise Value
19.40M
Trailing P/E
22.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.83
Price/Book (mrq)
0.97
Enterprise Value/Revenue
0.73
Enterprise Value/EBITDA
4.69
Financial Highlights
Profitability and Income Statement
Profit Margin
3.63%
Return on Assets (ttm)
3.39%
Return on Equity (ttm)
7.02%
Revenue (ttm)
25.84M
Net Income Avi to Common (ttm)
937.72k
Diluted EPS (ttm)
0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
10.9M
Total Debt/Equity (mrq)
35.05%
Levered Free Cash Flow (ttm)
-2.88M
Research Analysis: GME.DE
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: GME.DE
GME.DE does not have Company Insights